| Literature DB >> 28741930 |
Bing Bu1, Xin Tong2, Dechang Li1, Yachong Hu3,4, Wangxiao He4, Chunyu Zhao5, Rui Hu2, Xiaoqing Li2, Yongping Shao4, Cong Liu5, Qing Zhao2, Baohua Ji1, Jiajie Diao3.
Abstract
The abnormal aggregation of α-synuclein (α-Syn) is closely associated with Parkinson's disease. Different post-translational modifications of α-Syn have been identified and contribute distinctly in α-Syn aggregation and cytotoxicity. Recently, α-Syn was reported to be N-terminally acetylated in cells, yet the functional implication of this modification, especially in α-Syn oligomerization, remains unclear. By using a solid-state nanopore system, we found that N-terminal acetylation can significantly decrease α-Syn oligomerization. Replica-exchange molecular dynamics simulations further revealed that addition of an acetyl group at the N-terminus disrupts intermolecular hydrogen bonds, which slows down the initial α-Syn oligomerization. Our finding highlights the essential role of N-terminal acetylation of α-Syn in preserving its native conformation against pathological aggregation.Entities:
Keywords: N-terminal acetylation; Parkinson’s disease oligomerization; α-Synuclein
Mesh:
Substances:
Year: 2017 PMID: 28741930 DOI: 10.1021/acschemneuro.7b00250
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418